The Olanzapine Market Report (2019-2026): Opportunities, Challenges, Strategies, and Forecasts
According to the report, the global Olanzapine market is worth USD 205 million in 2019, and it is expected to generate USD 244 million in revenue by 2026, with a compound annual growth rate of roughly 2.5% from 2019 to 2026.
Olanzapine is an atypical antipsychotic drug, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis.
Get Free Sample at:
Market Driver and Constraint
The main factors affecting the market’s growth include the growing prevalence of neurological diseases (including schizophrenia, bipolar disorder, and other diseases) and an increase in the population of various countries. With the change of ways of life and the expanded anxiety in work and life achieved by the world’s monetary advancement, the frequency of emotional sickness and mental issues are developing. This may further increase the demand for olanzapine as a primary measure for the treatment of such diseases.
North America accounts for the largest market share of about more than 38.66% of the market share due to extensive use product by the patients in the regions, major manufacturers developing the product in the region. Furthermore, continuously rising incidences of neurological disorders like bipolar disorder and schizophrenia among individuals are accountable for the growth of this market in the North America region.
The European market is also gradually growing and slowly catching up with the American market in the future. Olanzapine was first introduced in Europe because a large number of individuals were diagnosed with mental diseases and neurological disorders. On the other hand, it is expected that the Asia-Pacific market of olanzapine market will grow at the fastest speed in the forecast period. In particular, India and China are anticipated to be the fastest growing markets. Many major players seeking opportunity and expand their presence in this region influencing the growth of the market. However, the Middle East and Africa have the least market share in Olanzapine due to lack of awareness, less market access, and poor medical facilities.
Purchase this report:
Characterized by the presence of several well-established and small players, the global market of olanzapine appears to be highly competitive and fragmented. With well-established market in the North America region, major companies have their home in the region and generate maximum market share. These companies have expanded their operating unit in various other emerging regions as well. In addition, other small and medium-sized enterprises are generating income from the local market.
Major enterprises in the global market of Olanzapine include Lilly, Teva Pharmaceutical, Dr. Reddy’s Laboratories, Apotex Inc., Mylan Pharmaceuticals, Par Pharmaceutical, Aurobindo Pharma, Torrent Pharmaceuticals, Jubilant Lifesciences, Sun Pharmaceutical, Sandoz, Hansoh Pharmaceutical, WATSON Pharmaceuticals (Changzhou), Zhejiang Langhua Pharmaceuticals, etc.
Worldwide Olanzapine Market by Type
Patent Type, Generics Type, and Other.
Worldwide Olanzapine Market by Application
Olanzapine Tablets, Other Medicine, and Other.
Table of Content
1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Olanzapine Market
2 Market Trends and Competitive Landscape
3 Segmentation of Olanzapine Market by Types
4 Segmentation of Olanzapine Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Olanzapine Market in Major Countries
7 North America Olanzapine Landscape Analysis
8 Europe Olanzapine Landscape Analysis
9 Asia Pacific Olanzapine Landscape Analysis
10 Latin America, Middle East & Africa Olanzapine Landscape Analysis
11 Major Players Profile
11.1.1 Lilly Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Teva Pharmaceutical
11.3 Dr. Reddy’s Laboratories
11.4 Apotex Inc.
11.5 Mylan Pharmaceuticals
11.6 Par Pharmaceutical
11.7 Aurobindo Pharma
11.8 Torrent Pharmaceuticals
11.9 Jubilant Lifesciences
11.10 Sun Pharmaceutical
11.12 Hansoh Pharmaceutical
11.13 WATSON Pharmaceuticals(Changzhou)
11.14 Zhejiang Langhua Pharmaceuticals
Ask for a discount at:
Distributors and resellers of Olanzapine
Olanzapine industry associations
Product managers, Olanzapine industry administrator, C-level executives of the industries
Research & Clinical Laboratories
Market research and consulting firms
Small and Medium-sized Enterprises (SMEs)
• Base Year: 2018
• Estimated Year: 2019
• Forecast Period: 2019 to 2026
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Name: Rebecca Hall
Phone: + 1 (347) 467 7721
Web Site: https://www.globalmarketmonitor.com